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Abstract
Background: Topical treatments such as Arnica cream and mucopolysaccharide polysulfuric acid (contained in Hirudoid 
cream) have been used to treat the bruising and pain arising from dialysis-related infiltrations.
Aim To undertake a randomised controlled pilot study comparing the efficacy of Arnica and Hirudoid creams in treating 
bruising and pain following post-needling infiltration.
Methods One dialysis centre of 40 patients over a 12-month period. Following infiltration, and at the five subsequent dialysis 
treatments, pain was measured using the Abbey pain scale and size of the bruise was recorded.
Results Eleven cases of infiltration were recorded consisting of seven males (64%) and four females (36%) who had a mean age 
of 78 years (SD=9). Access for eight patients was via arteriovenous fistula and for three patients via arteriovenous graft. Eight 
patients experienced bruising and two patients reported mild pain post-infiltration but there were no differences found between 
the effect of Arnica or Hirudoid in treating either symptom.
Conclusion This pilot study was unable to detect any differences in the effect of Arnica and Hirudoid on pain or bruising. The 
study demonstrated that a larger, multicentre trial would be required to power a study and that a non-interventional control 
group should be added.
Background
People receiving haemodialysis require access to large blood 
flows via the use of the native arteriovenous fistula (AVF), 
arteriovenous graft (AVG) or central venous dialysis catheter 
(CVDC). A frequent complication when using AVFs and 
AVGs is infiltration or extravasation (bruising caused by blood 
leaking into tissues around blood vessels) related to cannulation 
(needling) (Padberg et al., 2008). This can be minor, such as 
swelling with fistula usable for the next dialysis, major such as 
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significant bleeding and swelling requiring greater than seven 
days of recovery, or severe requiring blood transfusion treatment 
and/or hospital admission (Lee et al., 2011). Although most 
infiltrations are minor, the resulting bruising and pain can cause 
discomfort. Treatments ranging from pressure, topical creams and 
ice are used to minimise swelling and bruising (Lee et al., 2006). 
There remains, however, limited research informing effective 
treatment of post-infiltration bruising and pain.
Topical treatments such as Arnica and Hirudoid creams have 
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been used in the treatment of bruising and pain associated 
with dialysis needle infiltration of the AVF or AVG (Niu, 2009; 
Yang et al., 2008). Arnica is sourced from an organically grown 
alpine plant and is available without prescription, usually from 
homeopathic outlets. Arnica has been shown to have anti-
inflammatory and analgesic properties (Kouzi & Nuzum, 
2007) and has been used for centuries to treat muscle, joint and 
cartilage pain (Cohen et al., 2000). A small number of positive 
research findings have been reported (Reddy et al., 2013), 
including effective reduction of laser-induced bruising (Leu et 
al., 2010), oedema following rhinoplasty (Totonchi & Guyuron, 
2007), and ecchymosis following rhytidectomy (Seeley et al., 
2006). Despite these positive findings, the broader literature is 
equivocal and suggests that Arnica is no more effective than 
placebo in treating bruising, pain and swelling (Kouzi & Nuzum, 
2007).
Hirudoid cream contains mucopolysaccharide polysulphate 
(MPS), a semi-synthetic glycosaminoglycan with a mean 
molecular mass of 9700 with multifold actions. MPS has 
various effects on blood coagulation, fibrinolysis and platelet 
function (Haas et al., 2001). Creams containing MPS have been 
used for the topical treatment of superficial thrombophlebitis, 
haematomata, and sports injuries (Haas et al., 2001) and have 
been shown to reduce complications and extend the duration 
of AVFs for dialysis patients (Yang et al., 2008). There has been 
limited research comparing these two treatments and the success 
of these creams is unclear.
Aim
The aim of this pilot study was to compare the efficacy of 
Arnica and Hirudoid creams in treating bruising and pain 
following post-needling infiltration.
Methods
Sample
The study was conducted at one satellite haemodialysis unit in 
Melbourne, Australia. Inclusion criteria were: patients aged 18 
years and over, a functioning AVF or AVG, able to understand 
and converse in the English language, able to provide informed 
consent, receiving nurse-assisted haemodialysis for greater than 
three months, and experienced an episode of infiltration in 
the dialysis unit during the study period. Ethics approval was 
received from Monash Health (#11246Q).
Procedure
Patients who provided informed consent to participate in the 
study were alternately randomised to either the Arnica (n=6) or 
Hirudoid (n=5) group. Allocation to each treatment group was 
determined based on the selection of a sealed envelope by the 
treating nurse. The envelopes were locked in a filing cabinet and 
accessed when a patient was recruited. Treatment allocation and 
instructions were enclosed within the blank envelopes. There 
was an equal number of envelopes for Arnica and Hirudoid 
creams and the envelopes were shuffled each time a patient 
was recruited. It was not possible to know which treatment 
Table 1: Size of post-extravasation bruising (area mm2) 
Patient Time 1 Time 2 Time 3 Time 4 Time 5 Time 6
Arnica 1 0 0 0 0 0 0
Arnica 2 15 0 0 0 0 0
Arnica 3 9 4 0 0 0 0
Arnica 4 36 25 49 49 - -
Arnica 5 12 12 16 24 14 12
Arnica 6 104 100 100 100 - -
Hirudoid 1 0 0 0 0 0 0
Hirudoid 2 24 50 140 91 22 0
Hirudoid 3 20 16 16 16 0 0
Hirudoid 4 4 2 2 0 0 0
Hirudoid 5 0 0 0 0 0 0
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condition was selected until the envelope was opened. Before 
commencing any treatment, the size of any resultant bruising 
was measured and the level of patient pain was recorded. For 
both treatment conditions, the treatment was applied in the 
dialysis unit soon after infiltration occurred and the patient was 
provided with a tube of cream to apply twice per day to the 
affected area.
Data collection
Data collection commenced in July 2012 and continued for 
12 months. In the event of infiltration, data were collected 
that day and at the five subsequent haemodialysis treatments 
over a two-week period (that is, six data points). Patient pain/
discomfort was measured using the Abbey pain scale (Abbey et 
al., 2004). This scale contains six indicators of pain (for example, 
vocalisation, physiological change), rated on a four-point 
scale from 0 (absent) to 3 (severe). Scores for the six items are 
summed to produce a total pain score that can be classified as 
no pain (0–2), mild (3–7), moderate (8–13), or severe (14+). 
The size of the bruise (area mm2) was also recorded at each 
appointment over two weeks.
Data analysis
Data were entered into IBM SPSS Statistics, Version 22 (IBM 
Corp, Armonk, NY, USA). Comparative analyses were not 
feasible due to the unanticipated small sample sizes. Analysis 
was, therefore, limited to descriptive statistics (for example, 
frequencies, mean, SD).
Results
Over the 12 months of data collection, only 11 cases of post-
cannulation infiltration were recorded and all of these patients 
consented to participate in the study. This included seven males 
(64%) and four females (36%) who had a mean age of 78 years 
(SD=9, range=64–90 years). Access for six patients was via left 
AVF, for two patients via right AVF, and for three patients via 
right AVG.
Pain
On the day of the infiltration (Time 1), four patients in the 
Arnica group scored between 0 and 2 points (no pain) on 
the Abbey pain scale, and the remaining two patients scored 
between 3 and 7 points (mild pain). At all subsequent data 
collection points, participants in the Arnica group received a 
score of zero. All patients in the Hirudoid group received a 
score of zero on the day of the infiltration (Time 1) and at all 
subsequent data collection points.
Bruising
Three patients (Arnica n=1; Hirudoid n=2) experienced 
infiltration without any bruising. Of the remaining eight patients 
who experienced a bruise, the size on the day of infiltration 
ranged from 4–104 mm2 (Mean=28.00, SD=32.55) (Table 
1). The bruises for two participants in the Arnica group had 
disappeared completely by Time 3 but one patient had a bruise 
that was still evident by Time 6. Data for the remaining two 
participants were incomplete beyond Time 4. The bruise of one 
participant in the Hirudoid group had disappeared by Time 4, 
and one disappeared by Time 5; however, the bruise for the third 
participant increased to over five times its original size by Time 
3 before reducing back to its original size by Time 5.
Discussion
People receiving dialysis may experience unpleasant bruising 
and pain following cannulation-related infiltration (Dinwiddie 
et al., 2013) and this was clearly demonstrated in this study. Both 
Arnica and Hirudoid were associated with decreased bruising 
and pain; however, whether the creams made any difference 
than normal healing could not be confirmed. This pilot study 
was unable to detect any difference in the effect on pain and 
bruising of Arnica or Hirudoid.
Studies measuring the effects of Arnica and Hirudoid provide 
mixed results. Although Arnica has been shown to reduce 
bruising and swelling in small clinical trials (Levy & Emer, 
2012) other studies suggest only limited effects on bleeding, 
inflammation, pain or myocardial ischaemia (Cornu et al., 2010), 
postoperative pain, bruising and swelling (Stevinson et al., 2003) 
and no better than placebo for post eye surgery bruising (Perry, 
2011). Hirudoid has been shown to be effective in reducing 
bleeding-related complications (Yang et al., 2008) but the 
evidence is limited.
In this study only minor infiltrations occurred with no access 
losses recorded. Severe infiltrations can lead to access loss 
(Brouwer, 2011) and can delay access usage (Dinwiddie et al., 
2013). If Arnica and Hirudoid are effective in reducing pain 
and bruising, there may be clinical implications for these topical 
treatments in major or severe infiltrations.
The main function of a pilot study is to inform the methods and 
design for a future larger study. Over a 12-month period in a 40 
patient dialysis unit there were only 11 episodes of cannulation-
related infiltration that met the inclusion study criteria. Clearly 
an increased participant group from a greater number of dialysis 
centres would need to be included in order to power a larger 
study.
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Study limitations
The major limitations were the small number of recruited 
participants and the lack of a non-intervention control group.
Conclusion
This pilot study was unable to demonstrate any differences 
between the effect of Arnica or Hirudoid creams in reducing 
pain and bruising post-cannulation infiltration. The study 
highlighted the challenges in recruiting for this type of study. 
Over a period of 12 months in one 10-chair dialysis unit only 
11 occasions of infiltration were recruited into the study. A 
much greater population of more than one dialysis centre would 
be required to power a larger study. Results from a larger study 
may have relevance to other areas of cannulation (for example, 
oncology, haematology, emergency) and surgery.
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